CFO of National HealthCare (NYSE: NHC) exercises 1,853 options

Rhea-AI Filing Summary

National HealthCare Corp SVP and CFO Brian F. Kidd exercised stock options for 1,853 shares of common stock at an exercise price of $53.94 per share. The options were originally granted under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).

Following the transaction, Kidd directly holds 29,130 shares of common stock. He also continues to hold options over 8,000 shares at an exercise price of $94.10, 9,500 shares at $90.62, and 14,000 shares at $157.13, with expirations between 2029 and 2031.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

KIDD BRIAN F

(Last) (First) (Middle)

100 VINE STREET

(Street)

MURFREESBORO TN 37130

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
NATIONAL HEALTHCARE CORP [ NHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP, CFO

3. Date of Earliest Transaction (Month/Day/Year)
03/12/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/12/2026		M		1,853(1)	A	$53.94	29,130	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Stock	$53.94	03/12/2026		M			1,853(1)	03/08/2024	03/08/2028	Common Stock	6,000	$0	4,147	D
Option to Purchase Common Stock	$94.1							03/05/2025	03/05/2029	Common Stock	8,000		8,000	D
Option to Purchase Common Stock	$90.62							02/24/2026	02/24/2030	Common Stock	9,500		9,500	D
Option to Purchase Common Stock	$157.13							02/23/2027	02/23/2031	Common Stock	14,000		14,000	D

Explanation of Responses:

1. These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).

	/s/ Brian Kidd	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did NHC executive Brian F. Kidd report in this Form 4?

Brian F. Kidd, SVP and CFO of National HealthCare Corp, reported exercising options for 1,853 shares of common stock at $53.94 per share. The exercised options were granted under the 2020 Omnibus Equity Incentive Plan and are exempt from Section 16(b) under Rule 16b-3(d).

Did the NHC CFO buy or sell any common stock on the open market?

The filing shows an exercise of stock options, not an open-market purchase or sale. Kidd acquired 1,853 shares through option exercise at $53.94 per share and no sales, gifts, or tax-withholding dispositions are reported in this Form 4 transaction set.

How many NHC common shares does Brian F. Kidd hold after this transaction?

After the reported option exercise, Brian F. Kidd directly holds 29,130 shares of National HealthCare Corp common stock. This figure reflects his position following the 1,853-share acquisition through option exercise reported for the transaction date shown in the filing.

What stock option awards does the NHC CFO still have outstanding?

Kidd continues to hold options over 8,000 shares at $94.10, 9,500 shares at $90.62, and 14,000 shares at $157.13. These option grants are exercisable into common stock and have expiration dates ranging from 2029 through 2031 according to the derivative holdings summary.

Under which plan were the exercised NHC options originally granted?

The exercised stock options were granted under National HealthCare Corp’s 2020 Omnibus Equity Incentive Plan. The filing notes that both the grant and the exercise of these options are exempt from Section 16(b) short-swing profit rules pursuant to SEC Rule 16b-3(d).

What does the transaction code M mean in this NHC Form 4?

Transaction code M indicates an exercise or conversion of a derivative security, such as a stock option. Here, it reflects Kidd exercising options to acquire 1,853 shares of common stock at $53.94 per share, rather than buying or selling shares on the open market.